mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |